Datavant is a health information technology company based in Phoenix, Arizona, USA, which develops and maintains a digital ecosystem for the exchange of healthcare data.[1][2] Datavant's clients include clinical research organizations, pharmaceutical companies, payers, analytics companies, hospitals, and providers, operating primarily in the US healthcare market.[3]
Along with the Health Care Cost Institute, Snowflake, Elsevier, Parexel, and others, Datavant operates the COVID-19 Research Database, which "enables public health and policy researchers to use real-world data to understand and combat the COVID-19 pandemic."[4][5]
The company received a $40.5mm Series A investment in 2018 led by Roivant Sciences,[7] followed by a $40mm Series B investment in 2020.[citation needed] In June 2021, Datavant entered into a seven billion dollar deal to merge with the healthcare information management company Ciox Health.[8][9] Following the merger, May became president and joined the company's board, while Ciox's CEO Pete McCabe become the CEO of the joint entity that continued under the Datavant name.[10] Also in June 2021, Datavant announced a partnership with Biodesix, a data-driven diagnostics company.[11]
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
